Antiviral Chemotherapy 4
New Directions for Clinical Application and Research
The three years since our last conference in San Francisco have again seen a dramatic expansion of the number of antivirals either licensed or in the late stages of clinical trials. d4T is now licensed for HIV infection, famciclovir and the oral pro-drug of acyclovir, valacyclovir, are now licensed for VZV infections in some countries. Moreover. oral ganciclovir, cidofovir, and sorivudine are not far behind. Clinical trials with the second-site reverse transcriptase inhibitors and the protease inhibitors for HlV infection are proceeding rapidly and on a broad scale, and the preliminary results would suggest that several of these classes of dr…
Mehr
CHF 177.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
V210:
Noch nicht erschienen, Januar 2022
Produktdetails
Weitere Autoren: Volberding, Paul A. (Hrsg.) / Corey, Lawrence (Hrsg.)
- ISBN: 978-1-4757-9209-6
- EAN: 9781475792096
- Produktnummer: 38251955
- Verlag: Springer US
- Sprache: Englisch
- Erscheinungsjahr: 2013
- Seitenangabe: 440 S.
- Plattform: PDF
- Auflage: 1996
- Reihenbandnummer: 394
11 weitere Werke von John (Hrsg.) Mills:
Bewertungen
Anmelden